ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CELC vs CLOV // PIOTROSKI F-SCORE QUALITY

Celcuity Inc. (NASDAQ) VS. Clover Health Investments Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: CELC 2 — CLOV 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: CLOV
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELC VS. CLOV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CELC CLOV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -29.30% -5.70 CLOV /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.53% -2.84% -1.69 CLOV /fcf-yield <GO>
Operating Margin — -4.40% — TIE /operating-margins <GO>
Net Profit Margin — -4.40% — TIE /net-margins <GO>
Revenue Growth (YoY) — 40.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.62 — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 3/9 -1.00 CLOV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.3 45.3 +4.01 CELC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.39B $2.43B $958.3M CELC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CELC REV CLOV REV CELC GROSS % CLOV GROSS % CELC FCF CLOV FCF
FY 2025 $0 $1.92B — — -$153.5M -$69.0M
FY 2024 $0 $1.37B — — -$83.7M $33.3M
FY 2023 $0 $1.26B — — -$53.8M -$144.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELC // BETA —
CLOV // BETA —